机构

• 大连化学物理研究所 [63]
• 上海药物研究所 [17]
• 西北高原生物研究所 [9]
• 水生生物研究所 [3]
• 生态环境研究中心 [3]
• 金属研究所 [2]
• 更多

采集方式

• OAI收割 [98]
• iSwitch采集 [1]

内容类型

• 期刊论文 [88]
• 会议论文 [10]
• 学位论文 [1]

发表日期

• 2023 [2]
• 2022 [5]
• 2020 [1]
• 2019 [3]
• 2018 [3]
• 2017 [6]
• 更多

学科主题

• 物理化学 [11]
• 生物药物学 [2]
• Environmen... [1]
• 药学其他学科 [1]
• 药物化学 [1]

筛选

浏览/检索结果: 共99条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Pharmacokinetics,mass balance,and metabolism of 14C TPN171,a novel PDE5 inhibitor,in humans for the treatment of pulmonary arterial hypertension 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 卷号: 44, 期号: 1, 页码: 221 作者:  He Yifei;  Liu Yin;  Yu Jinghua;  Cheng Huan;  Odilov Abdullajon   |  收藏  |  浏览/下载：15/0  |  提交时间：2023/05/22 TPN171  14CTPN171  PDE5 inhibitor  pulmonary arterial hypertension  healthy volunteers  pharmacokinetics  metabolite identification  mass balance   Inhibition of estrogen sulfation by Xian-Ling-Gu-Bao capsule 期刊论文  OAI收割 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2023, 卷号: 225, 页码: 12 作者:  He, Liangliang;  Chen, Chanjuan;  Duan, Shuyi;  Li, Yang;  Li, Chuan   |  收藏  |  浏览/下载：29/0  |  提交时间：2022/11/11 Xian-Ling-Gu-Bao capsule  Estrogens  Sulfotransferase enzymes  Inhibitory effects  Molecular docking   Identification of naturally occurring inhibitors in Xian-Ling-Gu-Bao capsule against the glucuronidation of estrogens 期刊论文  OAI收割 FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13, 页码: 17 作者:  He, Liangliang;  Xu, Chunxia;  Wang, Ziying;  Duan, Shuyi;  Xu, Jinjin   |  收藏  |  浏览/下载：13/0  |  提交时间：2023/04/10 Xian-Ling-Gu-Bao capsule  estrogens  glucuronidation  inhibitory effects  UDP-glucuronosyltransferase   Pharmacokinetics, mass balance, and metabolism of [C-14]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertension 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 13 作者:  He, Yi-fei;  Liu, Yin;  Yu, Jing-hua;  Cheng, Huan;  Odilov, Abdullajon   |  收藏  |  浏览/下载：31/0  |  提交时间：2022/08/16 TPN171  [C-14]TPN171  PDE5 inhibitor  pulmonary arterial hypertension  healthy volunteers  pharmacokinetics  metabolite identification  mass balance   Pharmacokinetics, Mass Balance, and Metabolism of the Novel Urate Transporter 1 Inhibitor [14C]HR011303 in Humans: Metabolism Is Mediated Predominantly by UDP-Glucuronosyltransferase 期刊论文  OAI收割 DRUG METABOLISM AND DISPOSITION, 2022, 卷号: 50, 期号: 6, 页码: 798-808 作者:  Zheng, Yuandong;  Zhang, Hua;  Liu, Mengling;  Li, Guangze;  Ma, Sheng   |  收藏  |  浏览/下载：23/0  |  提交时间：2022/08/16 Absorption, metabolism, and excretion of [C-14]YY-20394, a highly selective PI3K-Delta inhibitor in humans 期刊论文  OAI收割 XENOBIOTICA, 2022, 页码: 11 作者:  Yu, Jinghua;  Zhang, Hua;  Zhang, Yifan;  Zhan, Yan;  Ma, Sheng   |  收藏  |  浏览/下载：36/0  |  提交时间：2022/06/15 YY-20394  [C-14]YY-20394  mass balance  drug metabolism  pharmacokinetics   Microplastics boost the accumulation of tetrabromobisphenol A in a commercial clam and elevate corresponding food safety risks 期刊论文  OAI收割 CHEMOSPHERE, 2022, 卷号: 292, 期号: 0, 页码: 133499 作者:  Zhang, Weixia;  Tang, Yu;  Han, Yu;  Zhou, Weishang;  Shi, Wei   |  收藏  |  浏览/下载：16/0  |  提交时间：2022/11/09 BROMINATED FLAME RETARDANTS  PYRUVATE-KINASE M2  DETOXIFICATION RESPONSES  MARINE-SEDIMENTS  OXIDATIVE STRESS  MYTILUS-EDULIS  P-GLYCOPROTEIN  TBBPA  EXPOSURE  BIOACCUMULATION   Sulfation predominates the pharmacokinetics, metabolism, and excretion of forsythin in humans: major enzymes and transporters identified 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 12 作者:  Pan, Lu-lu;  Yang, Yong;  Hui, Min;  Wang, Shuo;  Li, Cui-yun   |  收藏  |  浏览/下载：46/0  |  提交时间：2020/12/24 forsythin  pharmacokinetics  drug metabolism  drug excretion  sulfation  glucuronidation  organic anion transporter 3   Per- and polyfluoroalkyl substances display structure-dependent inhibition towards UDP-glucuronosyltransferases 期刊论文  OAI收割 ENVIRONMENTAL POLLUTION, 2019, 卷号: 254, 页码: - 作者:  Liu, Yong-Zhe;  Zhang, Zhi-Peng;  Fu, Zhi-Wei;  Yang, Kun;  Ding, Ning   |  收藏  |  浏览/下载：25/0  |  提交时间：2020/09/10 Per- and polyfluoroalkyl substances (PFASs)  UDP-Glucuronosyltransferases (UGTs)  Half inhibition concentration (IC50)  Inhibition type  Inhibition kinetic parameters (Ki)  In vitro-in vivo extrapolation (IVIVE)   Recent progress and challenges in screening and characterization of UGT1A1 inhibitors 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2019, 卷号: 9, 期号: 2, 页码: 258-278 作者:  Finel, Moshe;  Lv, Xia;  Xia, Yangliu;  Wu, Jingjing;  Ge, Guangbo   |  收藏  |  浏览/下载：73/0  |  提交时间：2019/06/20 UGT1A1 inhibitors  Drug/herbdrug interactions  Probe substrates  High-throughput screening